Increasing incidence of metastatic prostate cancer in the United States (2004-2013)

Prostate Cancer and Prostatic Diseases

Volumn 19, Issue 4, 2016, Pages 395-397

  Weiner, A B ^a   Matulewicz, R S ^a   Eggener, S E ^b   Schaeffer, E M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; HEALTH CARE FACILITY; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTATIC PROSTATE CANCER; MIDDLE AGED; PRIORITY JOURNAL; PROSTATE CANCER; UNITED STATES; EARLY CANCER DIAGNOSIS; INCIDENCE; PATHOLOGY; PROCEDURES; PROSTATE TUMOR;

AGED; EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 84978763825     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2016.30     Document Type: Article

References (10)

1. U. S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 185-191.
2. Moyer VAU. S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157: 120-134.
3. Jemal A, Fedewa SA, Ma J, Siegel R, Lin CC, Brawley O et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA 2015; 314: 2054-2061.
4. Drazer MW, Huo D, Eggener SE. National prostate cancer screening rates after the 2012 US Preventive Services Task Force recommendation discouraging prostatespecific antigen-based screening. J Clin Oncol 2015; 33: 2416-2423.
5. Mohler JL, Armstrong AJ, Bahnson RR, D'Amico AV, Davis BJ, Eastham JA et al. Prostate cancer, version 1.2016. J Natl Compr Canc Netw 2016; 14: 19-30.
6. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL et al. Early detection of prostate cancer: AUA guideline. J Urol 2013; 190: 419-426.
7. Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 2008; 100: 630-641.
8. Ortman JM, Velkoff VA, Hogan HAn Aging Nation: The Older Population in the United StatesCurrent Population Reports, P25-1140. US Census Bureau: Washington, DC, 2014.
9. Wu JN, Fish KM, Evans CP, Devere White RW, Dall'Era MA. No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period. Cancer 2014; 120: 818-823.
10. Weiner AB, Etzioni R, Eggener SE. Ongoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance. Eur Urol 2014; 66: 611-612.